Cargando…
Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
This review presents detailed information about the structure of triplet repeat RNA and addresses the simple sequence repeats of normal and expanded lengths in the context of the physiological and pathogenic roles played in human cells. First, we discuss the occurrence and frequency of various trinu...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245940/ https://www.ncbi.nlm.nih.gov/pubmed/21908410 http://dx.doi.org/10.1093/nar/gkr729 |
_version_ | 1782219911269974016 |
---|---|
author | Krzyzosiak, Wlodzimierz J. Sobczak, Krzysztof Wojciechowska, Marzena Fiszer, Agnieszka Mykowska, Agnieszka Kozlowski, Piotr |
author_facet | Krzyzosiak, Wlodzimierz J. Sobczak, Krzysztof Wojciechowska, Marzena Fiszer, Agnieszka Mykowska, Agnieszka Kozlowski, Piotr |
author_sort | Krzyzosiak, Wlodzimierz J. |
collection | PubMed |
description | This review presents detailed information about the structure of triplet repeat RNA and addresses the simple sequence repeats of normal and expanded lengths in the context of the physiological and pathogenic roles played in human cells. First, we discuss the occurrence and frequency of various trinucleotide repeats in transcripts and classify them according to the propensity to form RNA structures of different architectures and stabilities. We show that repeats capable of forming hairpin structures are overrepresented in exons, which implies that they may have important functions. We further describe long triplet repeat RNA as a pathogenic agent by presenting human neurological diseases caused by triplet repeat expansions in which mutant RNA gains a toxic function. Prominent examples of these diseases include myotonic dystrophy type 1 and fragile X-associated tremor ataxia syndrome, which are triggered by mutant CUG and CGG repeats, respectively. In addition, we discuss RNA-mediated pathogenesis in polyglutamine disorders such as Huntington's disease and spinocerebellar ataxia type 3, in which expanded CAG repeats may act as an auxiliary toxic agent. Finally, triplet repeat RNA is presented as a therapeutic target. We describe various concepts and approaches aimed at the selective inhibition of mutant transcript activity in experimental therapies developed for repeat-associated diseases. |
format | Online Article Text |
id | pubmed-3245940 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-32459402012-01-03 Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target Krzyzosiak, Wlodzimierz J. Sobczak, Krzysztof Wojciechowska, Marzena Fiszer, Agnieszka Mykowska, Agnieszka Kozlowski, Piotr Nucleic Acids Res Survey and Summary This review presents detailed information about the structure of triplet repeat RNA and addresses the simple sequence repeats of normal and expanded lengths in the context of the physiological and pathogenic roles played in human cells. First, we discuss the occurrence and frequency of various trinucleotide repeats in transcripts and classify them according to the propensity to form RNA structures of different architectures and stabilities. We show that repeats capable of forming hairpin structures are overrepresented in exons, which implies that they may have important functions. We further describe long triplet repeat RNA as a pathogenic agent by presenting human neurological diseases caused by triplet repeat expansions in which mutant RNA gains a toxic function. Prominent examples of these diseases include myotonic dystrophy type 1 and fragile X-associated tremor ataxia syndrome, which are triggered by mutant CUG and CGG repeats, respectively. In addition, we discuss RNA-mediated pathogenesis in polyglutamine disorders such as Huntington's disease and spinocerebellar ataxia type 3, in which expanded CAG repeats may act as an auxiliary toxic agent. Finally, triplet repeat RNA is presented as a therapeutic target. We describe various concepts and approaches aimed at the selective inhibition of mutant transcript activity in experimental therapies developed for repeat-associated diseases. Oxford University Press 2012-01 2011-09-09 /pmc/articles/PMC3245940/ /pubmed/21908410 http://dx.doi.org/10.1093/nar/gkr729 Text en © The Author(s) 2011. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Survey and Summary Krzyzosiak, Wlodzimierz J. Sobczak, Krzysztof Wojciechowska, Marzena Fiszer, Agnieszka Mykowska, Agnieszka Kozlowski, Piotr Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target |
title | Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target |
title_full | Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target |
title_fullStr | Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target |
title_full_unstemmed | Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target |
title_short | Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target |
title_sort | triplet repeat rna structure and its role as pathogenic agent and therapeutic target |
topic | Survey and Summary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245940/ https://www.ncbi.nlm.nih.gov/pubmed/21908410 http://dx.doi.org/10.1093/nar/gkr729 |
work_keys_str_mv | AT krzyzosiakwlodzimierzj tripletrepeatrnastructureanditsroleaspathogenicagentandtherapeutictarget AT sobczakkrzysztof tripletrepeatrnastructureanditsroleaspathogenicagentandtherapeutictarget AT wojciechowskamarzena tripletrepeatrnastructureanditsroleaspathogenicagentandtherapeutictarget AT fiszeragnieszka tripletrepeatrnastructureanditsroleaspathogenicagentandtherapeutictarget AT mykowskaagnieszka tripletrepeatrnastructureanditsroleaspathogenicagentandtherapeutictarget AT kozlowskipiotr tripletrepeatrnastructureanditsroleaspathogenicagentandtherapeutictarget |